2nd Quarter - Report

OB-GYNS FOR WOMEN'S HEALTH for AMERICAN COLLEGE OF OBSTETRICIANS & GYNECOLOGISTS

Firm
Client
Income
$140,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HPV Vaccination Mandate for Women and Girls; HR.463,The Prevention First Act;Repeal of Global Gag Rule; H. Con. Res. 48/S. Con. Res. 6, Women's Health Resolution; Comprehensive Sexuality Education funding (general); H.R. 1691/S.688, Breast Cancer Patient Protection Act. H.R.20/S.324, Melanie Blocker Stokes MOTHERS Act; H.R. 1558/S. 623, Pre-existing Condition Patient Protection Act.; Cord Blood Banking (general); S.670, Smoke Free Mothers and Babies Act of 2009; H.R. 3090, Health Equity and Accountability Act; H.R. 2635, Gender Equity in Health Premiums Act; S. 1303, Women's Health Insurance Fairness Act; H.R. 3200, Americas Affordable Health Choices Act; Stillbirth (general); Sudden unexpected infant deaths (general); Healthcare reform (general); Postpartum Depression (general);Vaccination Requirements for US Immigration;Emergency Contraception over the counter;Insurance Transparency (general);Pre-existing condition exclusion (general);Gender rating (general);Maternity Coverage (general);Medical Home Demonstration Progect(general);Alternatives to Medical Liability Reform Demonstration Project (general).

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
ANNA HYDE —
NEVENA MINOR —
JOSEF WEISSFELD —

Contacted: President of the U.S.; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); White House Office; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Bills named: S. 670 (111th), H.R. 3090 (111th), H.R. 463 (111th), S. 324 (111th), H.R. 2635 (111th), H.R. 20 (111th), H.R. 1691 (111th), H.R. 1558 (111th), S. 1303 (111th), S.Con.Res. 6 (111th), S. 623 (111th), S. 688 (111th), H.R. 3200 (111th), H.Con.Res. 48 (111th)

Indian/Native American Affairs IND

Funding for improvements to IHS.

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
ANNA HYDE —
NEVENA MINOR —
JOSEF WEISSFELD —

Contacted: White House Office; SENATE; President of the U.S.; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Medicare/Medicaid MMM

Medicare SGR reform (general); Imaging reimbursement.

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
ANNA HYDE —
NEVENA MINOR —
JOSEF WEISSFELD —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); President of the U.S.; SENATE; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Public health funding for National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Centers for Disease Control (CDC); Agency for Healthcare Research and Quality (AHRQ) for biomedical research; Comprehensive Sexuality Education funding (general); Affordable birth control; International family planning;

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
ANNA HYDE —
NEVENA MINOR —
JOSEF WEISSFELD —

Contacted: President of the U.S.; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); White House Office; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.